- Report
- August 2024
- 133 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- September 2024
- 188 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- September 2024
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- March 2024
- 677 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- July 2024
- 447 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 199 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 188 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 194 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2025
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2025
- 139 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- April 2024
- 136 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- February 2025
- 143 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- July 2024
- 137 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 179 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 880 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- November 2024
- 346 Pages
Global
From €3327EUR$3,500USD£2,795GBP
€4753EUR$5,000USD£3,993GBP

The Nucleic Acid Amplification (NAA) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. NAA is a technique used to detect and quantify nucleic acids, such as DNA and RNA, from a variety of sources. It is used in a wide range of applications, including clinical diagnostics, food safety testing, and environmental monitoring. NAA is a highly sensitive and specific method for detecting and quantifying nucleic acids, and is increasingly being used in IVD applications.
NAA technology is used in a variety of IVD tests, including infectious disease testing, genetic testing, and cancer diagnostics. It is also used in the development of new diagnostic tests, such as those for emerging infectious diseases. NAA technology is also being used in the development of personalized medicine, allowing for the detection of genetic mutations that may be associated with certain diseases.
The NAA market is expected to continue to grow in the coming years, driven by the increasing demand for IVD tests and the development of new technologies. Major players in the NAA market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Qiagen, and Thermo Fisher Scientific. Show Less Read more